Zhang et al.
FULL PAPER
Experimental
General
4.94 (br, 1H), 4.04 (s, 2H), 2.42 (s, 3H), 2.29 (s, 3H);
C NMR (100 MHz, CDCl ) δ: 143.4, 137.6, 136.9,
3
33.3, 129.7, 129.3, 127.9, 127.2, 47.0, 21.5, 21.1.
N-(4-Chlorobenzyl)-4-methylbenzenesulfonamide
H NMR (400 MHz, CDCl ) δ: 7.70 (d, J=
3
7.3 Hz, 2H), 7.26 (d, J=6.3 Hz, 2H), 7.19 (d, J=7.3 Hz,
2H), 7.11 (d, J=7.8 Hz, 2H), 5.34 (br, 1H), 4.05 (d, J=
1
3
1
1
13
H NMR and C NMR spectra were determined on
a Bruker Advance 400 spectrometer in CDCl at 400 and
00 MHz, respectively. Chloroform is used as the sol-
[2j]
1
3
(3d a)
3
1
vent with TMS as the internal standard, and the chemi-
cal shifts are referenced to signals at 7.26 and 77.0, re-
spectively. Mass spectra were detected on a Shimadzu
GC-MS-QP5050A spectrometer at an ionization voltage
of 70 eV equipped with a DB-WAX capillary column
13
5.0 Hz, 2H), 2.42 (s, 3H); C NMR (100 MHz, CDCl )
3
δ: 143.7, 136.8, 135.0, 133.6, 129.8, 129.3, 128.7, 127.1,
46.5, 21.5.
[3a]
4-Methyl-N-phenylbenzenesulfonamide (3e a)
1
1
(
internal diameter: 0.25 mm, length: 30 m).
3
H NMR (400 MHz, CDCl ) δ: 7.71 (d, J=8.2 Hz, 2H),
7
2
.59 (s, 1H), 7.19 (t, J=8.0 Hz, 4H), 7.11 (d, J=8.5 Hz,
H), 7.05 (t, J=7.2 Hz, 1H), 2.32 (s, 3H); C NMR
A typical procedure for the synthesis of arylsulfona-
mides
13
(
1
100 MHz, CDCl
3
) δ: 143.8, 136.6, 135.9, 129.6, 129.2,
27.2, 125.0, 121.2, 21.4.
-Methyl-N-(p-tolyl)benzenesulfonamide (3e
H NMR (400 MHz, CDCl ) δ: 7.66 (d, J=7.9 Hz, 2H),
.25 (br, 1H), 7.19 (d, J=7.8 Hz, 2H), 7.01-6.96 (m,
In a typical procedure, an undivided cell was
equipped with a Ni cathode (2 cm×2.5 cm×0.02 cm)
and a graphite rod anode. H O (10 mL), amines (1
2
[2k]
4
2
a)
1
3
mmol), sodium sulfinates (1.0 mmol) and NaI (4 mmol)
were in turn added to the undivided cell. The electroly-
sis was carried out in the undivided cell with constant
current (50 mA) for 1 h at room temperature. After the
electrolysis, the electrolyzed solution was continuously
stirred for 3 h so that sodium sulfinate with amine could
be completely converted to the target product. Then, the
solution was extracted with ethyl acetate (10 mL×3),
and the obtained organic layer was dried with anhydrous
7
4
13
H), 2.34 (s, 3H), 2.24 (s, 3H); C NMR (100 MHz,
) δ: 143.7, 136.1, 135.2, 133.9, 129.8, 129.6,
27.4, 122.1, 21.5, 20.9.
N-(4-Bromophenyl)-4-methylbenzenesulfonamide
CDCl
1
3
[
2i]
1
(
3e
3
a)
3
H NMR (400 MHz, CDCl ) δ: 7.67 (d, J=
7
.5 Hz, 2H), 7.33 (d, J=7.5 Hz, 2H), 7.26 (br, 1H), 7.23
(
d, J=7.8 Hz, 2H), 6.97 (d, J=7.5 Hz, 2H), 2.38 (s,
1
3
3
1
H); C NMR (100 MHz, CDCl
3
) δ: 144.2, 135.7,
4
MgSO . The solvent was removed by rotavapor under
35.7, 132.4, 129.8, 127.3, 123.0, 118.5, 21.56.
[
3a]
1
reduced pressure. The obtained crude product was puri-
fied by column chromatography on silica gel with pe-
troleum ether/ethyl acetate (5∶1) as eluent.
N,4-Dimethylbenzenesulfonamide (3f
NMR (400 MHz, CDCl ) δ: 7.75 (d, J=8.1 Hz, 2H),
.32 (d, J=8.0 Hz, 2H), 4.64 (br, 1H), 2.64 (d, J=5.0
1
a)
H
3
7
[3a]
1
13
4
-Tosylmorpholine (3aa)
H NMR (400 MHz,
Hz, 3H), 2.43 (s, 3H); C NMR (100 MHz, CDCl
1
3
) δ:
CDCl
3
) δ: 7.64 (d, J=8.1 Hz, 2H), 7.35 (d, J=8.0 Hz,
43.5, 135.8, 129.7, 127.2, 29.3, 21.5.
N-Ethyl-4-methylbenzenesulfonamide
[
3a]
2
2
1
H), 3.73 (t, J=4.8 Hz,4H), 2.98 (t, J=4.8 Hz, 4H),
2
(3f a)
13
1
.44 (s, 3H); C NMR (100 MHz, CDCl
32.1, 129.8, 127.9, 66.1, 46.0, 21.5.
3
) δ: 143.9,
H NMR (400 MHz, CDCl
3
) δ: 7.76 (d, J=8.2 Hz, 2H),
7
2
.31 (d, J=8.1 Hz, 2H), 4.61 (s, 1H), 3.03-2.96 (m,
1
3
N-(2-Hydroxyethyl)-N,4-dimethylbenzenesulfona-
H), 2.43 (s, 3H), 1.10 (t, J=7.2 Hz, 3H); C NMR
) δ: 143.3, 137.0, 129.7, 127.1, 38.2,
[3a]
1
mide (3ba)
3
H NMR (400 MHz, CDCl ) δ: 7.68 (d,
(
100 MHz, CDCl
3
J=7.9 Hz, 2H), 7.33 (d, J=7.8 Hz, 2H), 3.76 (s, 2H),
2
1.5, 15.0.
N-Butyl-4-methylbenzenesulfonamide
H NMR (400 MHz, CDCl ) δ: 7.75 (d, J=8.2 Hz, 2H),
.31 (d, J=8.0 Hz, 2H), 4.56 (s, 1H), 2.96-2.90 (m,
H), 2.43 (s, 3H), 1.47-1.40 (m, 2H), 1.33-1.24 (m,
[
3a]
3
.15 (s, 2H), 2.81 (s, 3H), 2.57 (br, 1H), 2.43 (s, 3H);
3
(3f a)
1
3
1
3
C NMR (100 MHz, CDCl ) δ: 143.7, 134.2, 129.8,
3
1
27.4, 60.2, 52.5, 36.0, 21.5.
7
2
2
N-(Furan-2-ylmethyl)-4-methylbenzenesulfona-
[
2i]
1
13
mide (3ca)
3
H NMR (400 MHz, CDCl ) δ: 7.71 (d,
H), 0.85 (t, J=7.3 Hz, 3H); C NMR (100 MHz,
J=7.6 Hz, 2H), 7.27 (d, J=7.0 Hz, 2H), 7.23 (s, 1H),
.20 (s, 1H), 6.08 (s, 1H), 5.00 (br, 1H), 4.16 (d, J=5.6
CDCl
1
3
) δ: 143.3, 137.0, 129.6, 127.1, 42.9, 31.6, 21.5,
6
9.7, 13.5.
13
[3a]
Hz, 2H), 2.41 (s, 3H); C NMR (100 MHz, CDCl
3
) δ:
N-tert-Butyl-4-methylbenzenesulfonamide (3f a)
4
1
1
4
49.6, 143.5, 142.5, 136.9, 129.7, 127.2, 110.4, 108.2,
H NMR (400 MHz, CDCl ) δ: 7.77 (d, J=8.2 Hz, 2H),
3
0.1, 21.5.
7.27 (d, J=8.3 Hz, 2H), 4.63 (br, 1H), 2.42 (s, 3H),
1.22 (s, 9H); C NMR (100 MHz, CDCl ) δ: 142.8,
140.5, 129.4, 127.0, 54.6, 30.1, 21. 5.
[3a]
13
N-Benzyl-4-methylbenzenesulfonamide (3d
1
a)
3
1
H NMR (400 MHz, CDCl
3
) δ: 7.73 (d, J=6.6 Hz, 2H),
[3a]
7
2
1
2
.28-7.17 (m, 7H), 5.06 (br, 1H), 4.09 (d, J=5.7 Hz,
H), 2.41 (s, 3H); C NMR (100 MHz, CDCl ) δ: 143.4,
3
36.8, 136.3, 129.6, 128.6, 127.8, 127.7, 127.1, 47.1,
1.4.
N-Hexyl-4-methylbenzenesulfonamide
5
(3f a)
1
3
1
H NMR (400 MHz, CDCl ) δ: 7.75 (d, J=8.1 Hz, 2H),
3
7.30 (d, J=8.0 Hz, 2H), 4.57-4.56 (m, 1H), 2.92 (m,
2H), 2.43 (s, 3H), 1.47-1.40 (m, 2H), 1.26-1.21 (m,
6H), 0.84 (t, J=6.7 Hz, 3H); C NMR (100 MHz,
13
4
-Methyl-N-(4-methylbenzyl)benzenesulfona-
[
2j]
1
mide (3d
2
a)
H NMR (400 MHz, CDCl
3
) δ: 7.74 (d,
CDCl ) δ: 143.3, 137.0, 129.6, 127.1, 43.2, 31.2, 29.5,
3
J=8.0 Hz, 2H), 7.28 (d, J=7.9 Hz, 2H), 7.06 (s, 4H),
26.1, 22.4, 21.5, 13.9.
2
www.cjc.wiley-vch.de
© 2016 SIOC, CAS, Shanghai, & WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Chin. J. Chem. 2016, XX, 1—6